The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Parkinson's disease subtypes: lost in translation?
Open accessAbstract
Like many neurodegenerative disorders, Parkinson's disease (PD) is clinically highly heterogeneous. A number of studies have proposed and defined subtypes of PD based on clinical features that tend to cluster together. These subtypes present an opportunity to refine studies of aetiology, course and treatment responsiveness in PD, as clinical variability must represent underlying biological or pathophysiological differences between individuals. In this paper, we review what subtypes have been identified in PD and the validation they have undergone. We then discuss what the subtypes could tell us about the disease and how they have been incorporated into studies of aetiology, progression and treatment. Finally, with the knowledge that they have been incorporated very little into PD clinical research, we make recommendations for how subtypes should be used and make some practical recommendations to address this lack of knowledge translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Variable expression of Parkinson's disease: A base‐line analysis of the DAT ATOP cohort
Jankovic, J., McDermott, M., Carter, J., Gauthier, S., Goetz, C., Golbe, L., Huber, S., Koller, W., Olanow, C., Shoulson, I., et al. (1990) · Neurology · doi:10.1212/wnl.40.10.1529 · Cited by 1,285
Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach
Lewis, S. J. G. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.033530 · Cited by 551
A clinico-pathological study of subtypes in Parkinson's disease
Selikhova, M., Williams, D. R., Kempster, P. A., Holton, J. L., Revesz, T., & Lees, A. J. (2009) · Brain · doi:10.1093/brain/awp234 · Cited by 461
Changes in motor subtype and risk for incident dementia in Parkinson's disease
Alves, G., Larsen, J. P., Emre, M., Wentzel‐Larsen, T., & Aarsland, D. (2006) · Movement Disorders · doi:10.1002/mds.20897 · Cited by 434
The progression of pathology in longitudinally followed patients with Parkinson’s disease
Halliday, G., Hely, M., Reid, W., & Morris, J. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0344-8 · Cited by 414
Course in Parkinson disease subtypes: A 39-year clinicopathologic study
Rajput, A. H., Voll, A., Rajput, M. L., Robinson, C. A., & Rajput, A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ae7af1 · Cited by 270
Occupation and Risk of Parkinsonism: A Multicenter Case-Control Study
Tanner, C. M., Ross, G. W., Jewell, S. A., Hauser, R. A., Jankovic, J., Factor, S. A., Bressman, S., Deligtisch, A., Marras, C., Lyons, K. E., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.195 · Cited by 267
Self-citationThe heterogeneity of idiopathic Parkinson's disease
Foltynie, T., Brayne, C., & Barker, R. A. (2002) · Journal of Neurology · doi:10.1007/pl00007856 · Cited by 255
The identification of Parkinson's disease subtypes using cluster analysis: A systematic review
van Rooden, S. M., Heiser, W. J., Kok, J. N., Verbaan, D., van Hilten, J. J., & Marinus, J. (2010) · Movement Disorders · doi:10.1002/mds.23116 · Cited by 238
Clinical subtypes of Parkinson's disease
van Rooden, S. M., Colas, F., Martínez‐Martín, P., Visser, M., Verbaan, D., Marinus, J., Chaudhuri, R. K., Kok, J. N., & van Hilten, J. J. (2011) · Movement Disorders · doi:10.1002/mds.23346 · Cited by 228
The association between motor subtypes and psychopathology in Parkinson's disease
Reijnders, J. S. A. M., Ehrt, U., Lousberg, R., Aarsland, D., & Leentjens, A. F. G. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.09.003 · Cited by 212
Prognostic factors for the progression of Parkinson's disease: A systematic review
Post, B., Merkus, M. P., de Haan, R. J., Speelman, J. D., & CARPA Study Group (2007) · Movement Disorders · doi:10.1002/mds.21537 · Cited by 206
Eggers, C., Kahraman, D., Fink, G. R., Schmidt, M., & Timmermann, L. (2011) · Movement Disorders · doi:10.1002/mds.23468 · Cited by 172
Recent developments in the pathology of Parkinson’s disease
Jellinger, K. A. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_33 · Cited by 170
Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease
Spiegel, J., Hellwig, D., Samnick, S., Jost, W., Möllers, M.-O., Fassbender, K., Kirsch, C.-M., & Dillmann, U. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-006-0518-2 · Cited by 169
Lewis, M. M., Du, G., Sen, S., Kawaguchi, A., Truong, Y., Lee, S., Mailman, R. B., & Huang, X. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.12.060 · Cited by 160
Graham, J., & SAGAR, H. J. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1<10::aid-mds1005>3.0.co;2-4 · Cited by 158
The heterogeneity of Parkinson’s disease
Wüllner, U., Borghammer, P., Choe, C., Csóti, I., Falkenburger, B. H., Gasser, T., Lingor, P., & Riederer, P. F. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02635-4 · Cited by 158
Rossi, C. A., Frosini, D., Volterrani, D., Feo, P. D., Unti, E., Nicoletti, V., Kiferle, L., Bonuccelli, U., & Ceravolo, R. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02898.x · Cited by 99
Clinical heterogeneity in newly diagnosed Parkinson’s disease
Post, B., Speelman, J. D., de Haan, R. J., & on behalf of the CARPA-study group (2008) · Journal of Neurology · doi:10.1007/s00415-008-0782-1 · Cited by 94
Invited Article: Changing concepts in Parkinson disease
Marras, C., & Lang, A. E. (2008) · Neurology · doi:10.1212/01.wnl.0000312515.52545.51 · Cited by 86
Self-citationDujardin, K., Defebvre, L., Duhamel, A., Lecouffe, P., Rogelet, P., Steinling, M., & Dest�e, A. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0549-2 · Cited by 72
Clinical predictors in Parkinson's disease
Gasparoli, E., Delibori, D., Polesello, G., Santelli, L., Ermani, M., Battistin, L., & Bracco, F. (2002) · Neurological Sciences · doi:10.1007/s100720200078 · Cited by 69
Mo, S. J., Linder, J., Forsgren, L., Larsson, A., Johansson, L. F., & Riklund, K. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1520-3 · Cited by 51
Parkinson's disease and nonmotor dysfunction (current clinical neurology)
Schrag, A. E. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074393 · Cited by 48
Vesper, J. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.3.275 · Cited by 47
Voluptuary habits and clinical subtypes of Parkinson's disease: The FRAGAMP case–control study
Nicoletti, A. S. Q., Pugliese, P., Nicoletti, G., Arabia, G., Annesi, G., Mari, M. D., Lamberti, P., Grasso, L., Marconi, R., Epifanio, A., et al. (2010) · Movement Disorders · doi:10.1002/mds.23297 · Cited by 38
Clinical heterogeneity in patients with early-stage Parkinson’s disease: a cluster analysis
Liu, P., Feng, T., Wang, Y., Zhang, X., & Chen, B. (2011) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1100069 · Cited by 35
Brain SPECT analysis by 3D-SSP and phenotype of Parkinson's disease
Mito, Y., Yoshida, K., Yabe, I., Makino, K., Tashiro, K., Kikuchi, S., & Sasaki, H. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.10.017 · Cited by 34
Navan, P., Findley, L. J. J., Jeffs, J. A. R., Pearce, R. K. B., & Bain, P. G. (2002) · Movement Disorders · doi:10.1002/mds.10320 · Cited by 33
SKEIE, G. O., Müller, B. P., Haugarvoll, K., Larsen, J. O., & Tysnes, O. (2010) · Movement Disorders · doi:10.1002/mds.23178 · Cited by 33
Abnormal metabolic brain networks in Parkinson’s disease
Tang, C. C., & Eidelberg, D. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84008-7 · Cited by 30
Sutherland, G. T., Siebert, G. A., Kril, J. J., & Mellick, G. D. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110026 · Cited by 27
Cited by
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Self-citationGut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Challenges in the diagnosis of Parkinson's disease
Tolosa, E., Garrido, A., Scholz, S. W., & Poewe, W. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00030-2 · Cited by 1,874
Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.197 · Cited by 598
Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis
John van Geest Centre for Brain Repair, D. O. C. N., Kouli, A., Torsney, K. M., Department of Medicine for the Elderly, C. U. H. N. F. T., Clinical Gerontology Unit, D. O. P. H. A. P. C., Kuan, W.-L., & John van Geest Centre for Brain Repair, D. O. C. N. (2018) · Parkinson’s Disease: Pathogenesis and Clinical Aspects · doi:10.15586/codonpublications.parkinsonsdisease.2018.ch1 · Cited by 507
Metadata
- Authors
- Marras, C., & Lang, A.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2012-09-05
- Volume
- 84
- Issue
- 4
- Pages
- 409-415
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2104406175
- Cited by
- 253
- References
- 34
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.